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ABSTRACT
Objective: To investigate the outcome for children
hospitalised with radiologically confirmed community-
acquired pneumonia (CAP)
Design: Controlled follow-up study.
Setting: Community based in Newcastle upon Tyne,
North Tyneside and Northumberland schools.
Patients: 103 cases of radiologically confirmed CAP a
median of 5.6 years (range 4.4–7.4) after admission to
Newcastle General Hospital, matched for sex and school
class to a mean of two controls (n = 248).
Interventions: A respiratory questionnaire, clinical
examination and spirometry measurements.
Main outcome measures: Multiple regression was
used to describe associations between explanatory
variables, including CAP, and outcome variables: forced
expiratory volume in 1 s percent predicted (FEV1 %),
forced vital capacity percent predicted (FVC %), persistent
cough, doctor diagnosis of asthma and abnormal chest
shape.
Results: Cases were 2.9 times more likely (95% CI 1.45
to 5.71, p = 0.020) than controls to have persistent
cough and 5.5 times more likely to have an abnormal
chest shape (95% CI 1.65 to 18.28, p = 0.005). Cases of
an atopic parent had a 7.0% deficit in FEV1 % predicted
(95% CI 210.5 to 23.2, p,0.001) and a 4.4% deficit in
FVC % predicted (95% CI 28.0 to 20.78, p = 0.017), but
were not at increased risk of subsequent asthma. Cases
of a non-atopic parent were at increased risk of
subsequent asthma (OR 4.8, 95% CI 1.43 to 16.34,
p = 0.011) but not of deficit in lung function.
Conclusions: CAP requiring admission to hospital is
associated with deficits in lung function and persistent
respiratory symptoms. This has implications for follow-up
for which recommendations are currently lacking. Parental
atopy may be a determinant of outcome.
There is increasing evidence from community
studies that long-term sequelae of community-
acquired pneumonia (CAP) in childhood include
asthma and deficits in lung function.1 2
Retrospective studies have also identified CAP to
be a risk factor in the development of bronchiec-
tasis.3 4 An association has been described between
pneumonia in early life and the development of
chronic obstructive pulmonary disease in adults,
implying that the consequences of CAP may be life
long.5 It has been proposed that the development
of CAP at a rapid stage of lung development may
impair lung growth and reduce subsequent lung
function, although an alternative explanation is
that pre-existing small airways may increase the
risk of developing CAP.1
It is likely that both the age of acquisition of
CAP and the severity of the disease are important
prognostic factors. A parental report of admission to
hospital with a lower respiratory tract infection
(LRTI) before the age of 5 years is a significant
independent predictor of deficit in forced expiratory
volume in 1 s (FEV1) and forced expiratory flow
during the mid portion of forced vital capacity (FVC)
(FEF25–75) after adjustment for current asthma and
wheeze.2 Such children were 5.3 times more likely to
suffer from persistent wheeze and 3.8 times more
likely to suffer from chronic cough at 5–11 years of
age than peers reported to have had an LRTI but not
admitted to hospital.2 However, few prospective
data are available to describe the outcome for
children hospitalised with CAP at the more severe
end of the disease spectrum. Hospital follow-up
studies have been limited by small numbers,6–8
inconsistent definition of CAP without supportive
radiological evidence,6 9 and by studies excluding
children acquiring CAP after 1 year of age.7 9
Uncomplicated CAP is currently considered to be a
self-limiting condition, and current guidelines issued
by the British Thoracic Society make no recommen-
dation for long-term follow-up.10
The aim of this study was to test the hypothesis
that children admitted to hospital with radiologi-
cally confirmed CAP are at increased risk of chronic
respiratory disease (CRD) in childhood.
MATERIALS AND METHODS
This was a controlled follow-up study. It was
conducted with the approval of the Directors of
What is already known on this topic
c Community-acquired pneumonia (CAP) is
associated with asthma and deficits in lung
function in childhood.
c CAP acquired in early life is associated with the
development of chronic obstructive pulmonary
disease in adults.
What this study adds
c Children with pre-existing asthma are at
significant risk of persistent cough after
admission to hospital with CAP.
c CAP requiring admission to hospital is
associated with deficit in lung function in
children of atopic parents and with subsequent
asthma in children of non-atopic parents.
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Education for Newcastle upon Tyne, North Tyneside and
Northumberland Local Education Authorities (LEAs), and ethics
approval was granted by the Newcastle and North Tyneside joint
local research ethics committee and the Northumberland local
research ethics committee. Written informed consent was
obtained from parents or guardians of all children participating
in the study.
Cases
Cases of CAP were obtained from a sample population of 159
children, 5–16 years of age at time of follow-up, admitted to
Newcastle General Hospital between 1 April 1995 and 1 June
1998.11 12 The combined group of 159 children consisted of those
who either participated in a CAP study,11 from 1 November
1996 to 1 June 1998 (n = 106), or a CAP audit,12 from 1 April
1995 to 31 March 1996 (n = 55). Two children participated in
both studies. All children fulfilled the same case definition of
CAP, presenting with an acute LRTI and radiological evidence
of pneumonia.11 12 CAP was defined by the presence of acute
respiratory symptoms (tachypnoea, respiratory distress, fever,
cough and wheeze) associated with compatible radiological
changes (collapse, consolidation, perihilar and peribronchial
changes).11 12 The admitting doctor decided if the child had
radiological features suggestive of pneumonia. The radiologist’s
report was taken as final, and children were excluded if the
report was normal. Neither the admitting doctor nor the
radiologist was blinded to the clinical presentation.11 12 The
sample population of 159 children included all children from
the CAP study and CAP audit referred direct from primary care
or self-referred by parents to the accident and emergency
department, and excluded referrals to the paediatric immunol-
ogy and infectious diseases team for tertiary management of
more complicated disease. All children were resident in the
geographical area covered by Newcastle upon Tyne, North
Tyneside and Northumberland LEAs at the time of hospital
admission.
Inclusion criteria at time of follow up were:
1. Resident within the geographical boundaries of the LEAs.
2. In full time education.
3. No physical or learning disability deemed by their head
teacher to preclude them from undertaking spirometry in a
reliable manner.
Controls
Each case was matched for age, sex and school class to a mean of
two controls by a process of random number selection from the
class register. Children were excluded if they had previously
been admitted to hospital with pneumonia or ‘‘chest infection’’.
Assessment
The purpose of the assessment was to identify children with
evidence of CRD (table 1) using a questionnaire, respiratory
examination, height and weight measurements and spirometry.
A questionnaire developed and validated for use in children by
the Institute of Respiratory Medicine in Sydney13 14 was
modified to include specific risk factors for the development
of CAP and CRD (supplemental file 1). We demonstrated good
intertester and intratester reproducibility of the modified
questionnaire, with Cohen’s k.0.6. (supplemental files 2 and
3, respectively).
Height was measured using a Seca Leicester Height Measure
(Hammer Steindamm, Hamburg, Germany), weight using
Salter 915 Stellar scales (Tonbridge, Kent, UK), and lung
function using the Vitalograph Compact II Spirometer (Maids
Moreton, Buckinghamshire, UK). FEV1 and FVC were adjusted
for age, sex, height and ethnic group and expressed as
percent predicted (FEV1 % and FVC %) according to
standard reference ranges18 19 and measured in accordance
with published guidelines.20 21
The level of community deprivation was assessed using the
Townsend score based on levels of unemployment, car and
home ownership, and overcrowding.22
Statistical analysis
Data were analysed using Stata Intercooled 7. Two-sample t
tests and Wilcoxon rank sum tests were used for continuous
variables, and x2 tests and Fisher’s exact tests were used for
categorical variables to determine if case participants and non-
participants differed, and if cases differed from controls in terms
of height and height standard deviation. The relationship
between CAP and the outcome variables FEV1 % predicted,
FVC % predicted, persistent cough, doctor diagnosis of asthma
and abnormal chest shape was investigated using logistic and
linear regression. Multivariate regression models were created
for all outcomes, except abnormal chest shape, as subject
numbers were too small (n = 13). The independent effect of risk
factors was obtained by forward and backward regression. The
goodness-of-fit was assessed using the Hosmer–Lemeshow
goodness-of-fit test for logistic regression models and the
Shapiro–Francia W9 test and inspection of residuals for normal-
ity for linear regression models.
RESULTS
The study inclusion criteria were fulfilled in 136 cases from the
case sample population of 159. Of the 23 not contacted, 12 had
moved out of the geographical boundaries of the participating
LEAs, five were of unknown address, three were unable to
undertake spirometry measurements because of a physical
disability, and three had died. All three deaths were unrelated
to the episode of CAP. Consent was obtained from 103 of the
136 cases invited to participate in the study. The median time
period from hospital admission with radiologically confirmed
CAP to follow-up was 5.6 years (range 4.4–7.4). There was no
significant difference between case participants and case non-
participants for age, sex, Townsend score, age or year of
admission with CAP. A total of 248 school class controls
Table 1 Definition of chronic respiratory disease outcomes
Chronic respiratory disease
outcome Definition
Persistent cough14 Cough lasting for .3 weeks in the absence of a
‘‘cold or flu’’ in the last 12 months
Frequent wheeze14 Wheeze on >4 occasions in the last 12 months
Signs of chronic respiratory
disease in the absence of an
intercurrent respiratory tract
infection15–17
Inspection: central cyanosis, clubbing,
tachypnoea, use of accessory muscles, prolonged
expiration, chest wall deformity (barrel chest,
pectus carinatum, pectus excavatum, Harrison’s
sulcus, sternal bowing), cough (wet, brassy,
barking or rattly), hoarse voice, dysphonia
Palpation: tracheal deviation, asymmetrical wall
expansion
Percussion: hyper-resonance, dullness
Auscultation: stridor, wheeze, stertor, ruttles,
crepitations, bronchial breath sounds
Abnormal lung function18 19 FEV1 or FVC .2 standard deviations below mean
reference data for age, sex, race and height
FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity.
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participated in the study. Fifteen controls were excluded from
the final analysis as they had been hospitalised previously with
bronchiolitis.
A conditional logistic regression analysis was adjusted for
Townsend score. This showed that there was no significant
difference between cases and controls for gestational age,
adjusted birth weight, history of exclusive breast feeding before
weaning, nursery school attendance, age of starting nursery
school, parental age at time of birth, parental history of asthma,
eczema or hayfever or parental smoking during pregnancy or
the first 2 years of the child’s life.
Tables 2 and 3 give the results of the univariate analyses.
Cases were at significantly increased risk of persistent cough,
doctor diagnosis of asthma, and an abnormal chest shape. Cases
also displayed deficits in FEV1 % predicted and FVC % predicted
when compared with controls.
The primary multivariate analyses investigated the associa-
tion between the CRD outcome variables and the explanatory
variables highlighted in tables 4 and 5. ‘‘Asthma’’ and ‘‘CAP’’
were combined for the purpose of the persistent cough
multivariate analysis to determine if the temporal relationship
between doctor diagnosis of asthma and CAP was important to
outcome. The goodness-of-fit of all models in the multivariate
analysis was found to be satisfactory.
Persistent cough
Table 4 shows the final model. Among children with a pre-
existing diagnosis of asthma, the risk of persistent cough was
5.33 for children with CAP (95% CI 0.54 to 54.3, p = 0.16)
compared with children without CAP. This was three times
larger than the equivalent risk observed among children without
pre-existing asthma (OR 1.73, 95% CI 0.65 to 4.56, p = 0.27).
Therefore the coexistence of pre-existing asthma with CAP
conferred the greatest risk of persistent cough.
Lung function
A maternal history of asthma and paternal history of eczema
were associated with significant deficits in FEV1 % predicted
and FVC % predicted in the child (table 5). A paternal history of
eczema was also related to FVC % predicted. CAP was not
shown to be a significant independent risk factor in either
model and therefore a supplemental analysis were performed to
investigate whether the deficit in lung function observed in the
univariate analysis (table 3) was attributable to parental atopy
rather than a direct effect of CAP. Parental atopy was defined by
a reported maternal or paternal history of at least one atopic
variable, ie, eczema, asthma or hayfever. Among children of an
atopic parent, those with a history of CAP had a 7.0% deficit in
FEV1 % predicted (95% CI210.5 to23.21, p,0.001) and a 4.4%
deficit in FVC % predicted (95% CI 28.02 to 20.78, p = 0.02)
compared with children of an atopic parent without a history of
CAP. Conversely, among children of non-atopic parents, those
with a history of CAP did not have a significant deficit in either
FEV1 % predicted (regression coefficient 3.72, 95% CI 20.65 to
8.08, p = 0.10) or FVC % predicted (regression coefficient 2.08,
95% CI 22.07 to 6.23, p = 0.32) compared with children of non-
atopic parents without a history of CAP.
Doctor diagnosis of asthma
A history of CAP was significantly associated with a doctor
diagnosis of asthma in the child (OR 2.8, 95% CI 1.27 to 5.75,
p = 0.01), as was a paternal history of eczema (OR 3.5, 95% CI
1.37 to 9.53, p = 0.009). A supplemental analysis was performed
to determine whether the risk of a new doctor diagnosis of
asthma differed according to CAP and parental atopic status.
Children of atopic parents without a pre-existing diagnosis of
asthma were not shown to be at a greater risk of subsequent
asthma after CAP (OR 1.5, 95% CI 0.65 to 3.48, p = 0.34)
compared with children of atopic parents without a pre-existing
diagnosis of asthma or a history of CAP. However, children of
non-atopic parents without a pre-existing diagnosis of asthma
had a 4.8-fold risk of subsequent asthma after CAP (95% CI 1.4
to 16.3, p = 0.01) compared with children of non-atopic parents
without pre-existing asthma or a history of CAP.
DISCUSSION
This study provides new evidence on the medium-term
outcome for UK children hospitalised with CAP. CAP is an
independent risk factor for persistent cough and asthma. In
children without pre-existing asthma, CAP was associated with
a high risk of subsequent asthma only in those children of non-
atopic parents. Conversely, CAP was associated with a deficit in
lung function only in those children of atopic parents. Hence,
parental atopy appears to be a determinant of outcome.
A number of studies have reported an association between
LRTI and asthma.1 9 23 24 Previous studies have also shown CAP
to be the single most significant risk factor for persistent
cough.25 26 In a cross-sectional study of 974 children aged 3–5
years, Haby et al23 showed that the risk of asthma was
significantly increased by atopy, parental history of asthma
and a serious LRTI in the first 2 years of life. A birth cohort
study on the Isle of White identified positive skin prick tests at 4
years, a family history of asthma, and recurrent chest infection
at 2 years of age as significant independent risk factors for the
persistence of early-life wheeze up to the age of 10 years.24 A
causative relationship between CAP and asthma has been
Table 2 Univariate analysis: categorical outcomes
Outcome Status Number (%) OR (95% CI) p Value
Persistent cough Case
Control
20 (19)
18 (8)
2.9 (1.5 to 5.7) 0.020
Doctor diagnosis of
asthma
Case
Control
24 (23)
26 (11)
2.2 (1.2 to 4.2) 0.012
Abnormal chest
shape
Case
Control
9 (9)
4 (2)
5.5 (1.7 to 18.3) 0.005
Table 3 Univariate analysis: continuous outcomes
Outcome Status Number (%)
Mean %
predicted
(SD)
Regression
coefficient
(95% CI) p Value
FEV1 % predicted Case
Control
93 (90)
219 (94)
90 (11)
94 (11)
23.5 (26.2 to 20.9) 0.010
FVC % predicted Case
Control
93 (94)
219 (94)
93 (10)
96 (10)
22.4 (24.9 to 0.6) 0.056
FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity.
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postulated, although reverse causation is an equally plausible
hypothesis. It is possible that symptoms, signs and radiological
findings of an LRTI might be confused with those of asthma,
and that children with asthma may be predisposed to
developing symptoms of cough and wheeze with an LRTI.
The observation that children at risk of developing an LRTI in
early childhood have pre-existing increased bronchial respon-
siveness and deficits in expiratory flow supports the concept of
a pre-existing airway abnormality.1
Parental atopy was a determinant of outcome with respect to
lung function and asthma in our cohort. Our findings are
consistent with evidence from community studies in Europe
where a history of recurrent LRTI27 or fever requiring antibiotics
in the first 3 years of life28 has been shown to be significantly
associated with a history of asthma at school age in children of
non-atopic parents but not in those of atopic parents. The
relationship between CAP and atopy is not clear and subject to
debate.27–29 Non-atopic individuals show a rapid transition from
the Th2 response at birth to a more balanced Th1/Th2 response,
but this transition is delayed in children predisposed to atopy.30
Natural immunity to bacterial and viral infection induces a Th1-
type response, and it has been postulated that CAP acquired in
early life may have a protective effect against subsequent
development of asthma in children predisposed to atopy, by
deviating the immune system away from the atopic state.29 31–33
Our findings show that among children with neither pre-
existing asthma nor atopic parents, those with a subsequent
history of CAP were at a significantly increased risk of a doctor
diagnosis of asthma at follow-up compared with children who
did not develop CAP. This implies that either these children had
an impaired pre-existing Th1 response or that their immune
response was deviated towards a Th2 response by the LRTI.
Th2 responses have been shown after infection with respiratory
syncytial virus in guinea pigs and rats,34 and have been
implicated in humans by demonstration of low interferon c
and relatively high interleukin 4 concentrations.35 Further
prospective studies are required to investigate the relationship
between the immune response to bacterial and viral LRTIs and
the development of atopy.
Study participants with one or more CRD outcomes (table 1)
were invited for assessment at a tertiary paediatric respiratory
clinic. The clinic diagnosis for the subgroup who attended is
shown in supplemental file 4. It was concluded that the deficits
in lung function observed in children with CAP who had an
atopic parent may be explained, in part, by chronic respiratory
morbidity other than, or in addition to, asthma. However, the
relationship between CAP, atopy and CRD, including non-
cystic fibrosis bronchiectasis and obliterative bronchiolitis,
requires further investigation.
This study benefited from prospective ascertainment and
radiological confirmation of CAP and is, to our knowledge, the
largest controlled follow-up study investigating the medium-
term outcome of such a carefully defined cohort of children. The
study has a number of limitations. Preferential recall bias is a
well-recognised problem of data collection by questionnaire.36
Limitations of a parental report of atopy are acknowledged.
Although case participants were shown to be no different from
non-participants, we have no data to determine whether disease
severity influenced recruitment. The retrospective nature of this
study did not allow pre-morbid assessment of lung function or
prospective documentation of respiratory morbidity, therefore
it is not possible to assess the role of CAP as a causative factor in
the development of impaired lung function or CRD.
The current British Thoracic Society guidelines make no
recommendation for long-term follow-up of children admitted
to hospital with CAP.10 We have shown that CAP is a marker for
a group of children at risk of CRD. Children with pre-existing
asthma and offspring of atopic parents are especially vulnerable.
Follow-up of all such children would be unrealistic, particularly
in terms of cost benefit for a deficit in lung function which may
not be of immediate clinical significance. However, this deficit
cannot be discounted, as CAP is known to be a risk factor for
the development of chronic obstructive pulmonary disease in
later life.5 Further prospective work is required to delineate these
groups further and to investigate an appropriate follow-up
strategy. We suggest that, parents of children admitted with
CAP should be counselled, at the time of discharge, to consult
their doctor if they are concerned about the possibility of
persistent cough, wheeze or asthma in their child in the future.
The results of this study also have implications for primary
prevention strategies including vaccination against important
bacterial and viral pathogens aimed at reducing the overall
burden of disease related to CAP in children.
Table 4 Multivariate analysis for persistent cough
OR (95% CI) p Value
Father eczema 5.73 (1.98 to 16.6) 0.001
Asthma and CAP 0.030
No pre-CAP asthma + no CAP
+ no post-CAP asthma
1.00 (–) –
No pre-CAP asthma + no CAP
+ post-CAP asthma
1.02 (0.24 to 4.26) 0.982
No pre-CAP asthma + CAP
+ no post-CAP asthma
1.85 (0.53 to 6.47) 0.334
No pre-CAP asthma + CAP
+ post-CAP asthma
1.76 (0.39 to 7.83) 0.461
Pre-CAP asthma + no CAP 1.58 (0.17 to 15.0) 0.690
Pre-CAP asthma + CAP 10.5 (2.97 to 37.0) ,0.001
Factors entered into the regression model were: ‘‘asthma and CAP’’, current age, sex,
Townsend score,22 born before 38 weeks’ gestation, birth weight adjusted for
prematurity, exclusively breast fed before weaning, attended nursery, age of starting
nursery, father’s age at child’s birth, mother’s age at child’s birth, father’s educational
level, mother’s educational level, hayfever in the last 12 months, eczema in the last
12 months, paternal eczema, paternal asthma, paternal hayfever, maternal eczema,
maternal asthma, maternal hayfever, number in household, father smoked during first
2 years of child’s life, mother smoked in pregnancy or during first 2 years of child’s life,
current smoking in household. Only factors showing significance at the final step of the
regression model are shown (p,0.05).
CAP, community-acquired pneumonia.
Table 5 Multivariate analysis for FEV1 and FVC % predicted
Regression coefficient (95% CI) p Value
FEV1 % predicted
Mother asthma 26.04 (29.91 to 22.17) 0.002
Father eczema 26.01 (210.2 to 21.82) 0.005
FVC % predicted
Father eczema 26.59 (210.4 to 22.69) 0.001
Mother asthma 23.67 (27.74 to 20.08) 0.045
Father hayfever 3.29 (20.50 to 6.07) 0.021
Factors entered into the regression model were: previous CAP, current age, sex,
Townsend score,22 born before 38 weeks gestation, birth weight adjusted for
prematurity, exclusively breast fed before weaning, attended nursery, age of starting
nursery, father’s age at child’s birth, mother’s age at child’s birth, father’s educational
level, mother’s educational level, doctor diagnosis of asthma, hayfever in the last
12 months, eczema in the last 12 months, paternal eczema, paternal asthma, paternal
hayfever, maternal eczema, maternal asthma, maternal hayfever, number in
household, father smoked during first 2 years of child’s life, mother smoked in
pregnancy or during first 2 years of child’s life, current smoking household. Only
factors showing significance at the final step of the regression model are shown
(p,0.05).
FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity.
Original article
758 Arch Dis Child 2008;93:755–759. doi:10.1136/adc.2007.128900
 group.bmj.com on June 8, 2010 - Published by adc.bmj.comDownloaded from 
Acknowledgements: We are grateful to the Sir Halley Stewart Trust, the Children’s
Research Fund and Wyeth Pharmaceuticals for financial support. We also thank Mrs
Jayne Kelly (research nurse), Dr Paula Drummond, Dr Tanya Dodman and Dr Julia Clark
for their meticulous data collection at the time of admission with CAP and provision of
original data sheets, Dr Jennifer Peat for provision of the Institute of Respiratory
Medicine Sydney Children’s Questionnaire, Mrs Katharine Kirton for data entry and
secretarial support, and Mr Richard Hardy for database preparation. We are also
grateful to the Newcastle upon Tyne, Northumberland and North Tyneside LEAs and
participating schools, parents and children without whom the study would not have
been possible.
Funding: Sir Halley Stewart Trust, the Children’s Research Fund, Wyeth
Pharmaceuticals.
Competing interests: KME conducted the community-acquired pneumonia study
supported by a grant received by DS from Wyeth Pharmaceuticals. Wyeth
manufacture a pneumococcal vaccine. The study was not biased as the result of
financial support from Wyeth. DH has no declared conflict of interest. LP does not have
any financial relationship with a commercial entity that has an interest in the subject of
this paper.
Ethics approval: Ethics approval was given by the Newcastle and North Tyneside
joint local research ethics committee and the Northumberland local research ethics
committee.
REFERENCES
1. Castro-Rodriguez JA, Holberg CJ, Wright AL, et al. Association of radiologically
ascertained pneumonia before age 3 yr with asthmalike symptoms and pulmonary
function during childhood. Am J Respir Crit Care Med 1999;159:1891–7.
2. Gold DR, Tager IB, Weiss ST, et al. Acute lower respiratory tract illness in childhood
as a predictor of lung function and chronic respiratory symptoms. Am Rev Respir Dis
1989;140:877–84.
3. Eastham KM, Fall AJ, Spencer DA, et al. The need to redefine non-cystic fibrosis
bronchiectasis in childhood. Thorax 2004;59:324–7.
4. Lewiston NJ. Bronchiectasis in childhood. Pediatr Clin North Am 1984;31:865–78.
5. Barker DJ, Godfrey KM, Fall C, et al. Relation of birth weight and childhood
respiratory infection to adult lung function and death from chronic obstructive airways
disease. BMJ 1991;303:671–5.
6. Korppi ML, Kuikka T, Reijonen, et al. Bronchial asthma and hyperreactivity after early
childhood bronchoilitis or pneumonia. Arch Paediatr Adolesc Med 1994;148:1079–84.
7. Mok JY, Simpson H. Outcome of acute lower respiratory tract infection in infants:
preliminary report of seven-year follow-up study. BMJ 1982;285:333–7.
8. Mok JY, Simpson H. Outcome for acute bronchitis, bronchiolitis, and pneumonia in
infancy. Arch Dis Child 1984;59:306–9.
9. Pullan CR, Hey EN. Wheezing, asthma, and pulmonary dysfunction 10 years after
infection with respiratory syncytial virus in infancy. Br Med J (Clin Res Ed)
1982;284:1665–9.
10. British Thoracic Society Standards of Care Committee. British Thoracic Society
Guidelines for the Management of Community Acquired Pneumonia in Childhood.
Thorax 2002;57(Suppl 1):i1–24.
11. Drummond P, Clark J, Wheeler J, et al. Community acquired pneumonia: a
prospective UK study. Arch Dis Child 2000;83:408–12.
12. Dodman T, Clark J, Cant AJ. Community acquired pneumonia: review of
investigations, aetiology, treatment and outcome for inpatients from a UK centre.
Eur J Pediatr 1999;158:1005.
13. Gray EJ, Peat JK, Mellis CM, et al. Asthma severity and morbidity in a population
sample of Sydney school children. Part I. Prevalence and effect of air pollutants in
coastal regions. Aust N Z J Med 1994;24:168–75.
14. Faniran AO, Peat JK, Woolcock AJ. Measuring persistent cough in children in
epidemiological studies; development of a questionnaire and assessment of
prevalence in two countries. Chest 1999;115:434–9.
15. Chang AB, Powell CV. Non-specific cough in children: diagnosis and treatment. Hosp
Med 1998;59:680–4.
16. Reisman JJ, Canny GJ, Levison H. The approach to chronic cough in childhood. Ann
Allergy 1988;61:163–9.
17. Taussig LM, Landau LI, Le Souef PN, et al. Clinical assessment and diagnostic
approach to common problems. In: Morgan WJ, ed. Pediatric respiratory medicine.
1st edn. St Louis, MO: Mosby, 1999:136–52.
18. Quanjer PH, Borsboom GJ, Brunekreff B, et al. Spirometric reference values for
white European children and adolescents: Polgar revisited. Pediatr Pulmonol
1995;19:135–42.
19. Vijayan VK, Reetha AM, Kuppurao KV, et al. Pulmonary function in normal south
Indian children aged 7 to 19 years. Indian J Chest Dis Allied Sci 2000;42:147–56.
20. American Thoracic Society. Standardization of spirometry: 1987 update. Am Rev
Respir Dis 1987;136:1285–98.
21. Official statement of the European Respiratory Society. Standardized lung
function testing. Eur Respir J Suppl 1993;16:1–100.
22. Townsend P, Phillimore P, Beattie A. Health and deprivation: inequalities in the
North. London: Routledge, 1998:21.
23. Haby MM, Peat JK, Marks GB, et al. Asthma in preschool children: prevalence and
risk factors. Thorax 2001;56:589–95.
24. Kurukulaaratchy RJ, Matthews S, Holgate ST, et al. Predicting persistent disease
amongst children who wheeze during early life. Eur Respir J 2003;22:767–71.
25. Wright AL, Holberg CJ, Morgan WJ, et al. Recurrent cough in childhood and its
relation to asthma. Am J Respir Crit Care Med 1996;153(4 Pt 1):1259–65.
26. Faniran AO, Peat JK, Woolcock AJ. Persistent cough: is it asthma? Arch Dis Child
1998;79:411–14.
27. Nja F, Nystad W, Hetlevik O, et al. Airway infections in infancy and the presence of
allergy and asthma in school age children. Arch Dis Child 2003;88:566–9.
28. von Mutius E, Illi S, Hirsch T, et al. Frequency of infections and risk of asthma, atopy
and airway hyperresponsiveness in children. Eur Respir J 1999;14:4–11.
29. Koopman LP, Smit HA, Heijnen ML, et al. Respiratory infections in infants:
interaction of parental allergy, child care, and siblings: The PIAMA study. Pediatrics
2001;108:943–8.
30. Babu KS, Arshad SH. The role of allergy in the development of airway inflammation
in children. Paediatr Respir Rev 2003;4:40–6.
31. Holt PG, Sly PD, Bjorksten B. Atopic versus infectious diseases in childhood: a
question of balance? Pediatr Allergy Immunol 1997;8:53–8.
32. Holt PG. Infections and the development of allergy. Toxicol Lett 1996;86:205–10.
33. Openshaw PJ, Hewitt C. Protective and harmful effects of viral infections in
childhood on wheezing disorders and asthma. Am J Respir Crit Care Med
2000;162:S40–3.
34. Mallia P, Johnston SL. Respiratory viruses: do they protect from or induce asthma?
Allergy 2002;57:1118–29.
35. Roman M, Calhoun WJ, Hinton KL, et al. Respiratory syncytial virus infection in
infants is associated with predominant Th-2-like response. Am J Respir Crit Care Med
1997;156:190–5.
36. Watkins CJ, Burton P, Leeder S, et al. Doctor diagnosis and maternal recall of lower
respiratory illness. Int J Epidemiol 1982;11:62–6.
Original article
Arch Dis Child 2008;93:755–759. doi:10.1136/adc.2007.128900 759
 group.bmj.com on June 8, 2010 - Published by adc.bmj.comDownloaded from 
